Nayoung Kim, Soowung Park, G. Seo
Dec 1, 2008
Citations
3
Influential Citations
25
Citations
Quality indicators
Journal
Helicobacter
Abstract
Background and Aims: Lafutidine is a novel H2‐receptor antagonist with gastroprotective activity that includes enhancement of gastric mucosal blood flow. The aim of the present study was to test the efficacy of 7‐ or 14‐day lafutidine–clarithromycin–amoxicillin therapy versus a lansoprazole‐based regimen for Helicobacter pylori eradication.